Antibody drug conjugate programs (ADCs) are growing fast in oncology, combining selectivity with high potency.

Information contained on this page is provided by an independent third-party content provider. XPRMedia and this Site make no warranties or representations in connection therewith ...

Guide covers ISO 17025 lab requirements and how brands can verify compliance before choosing a testing partner. IRVINE, ...

Researchers at The University of Manchester have created a physics‑informed machine‑learning model that can run molecular ...